Browse our catalogue of products
22 products displayed
Ref-SKU | Type | Product | Description | ICTV Taxonomy | Virus name | Strain | Isolate | Product Grading | Availability | Product Risk Group | Provider | Cost per Access (Academics) | More info | Add to Cart |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
006N-01987 | Nucleic Acid |
pHIV-1_pr45I-47V-50V
Antiviral resistant strain |
Plasmid contains the entire genome of HIV-1 (NL4-3) with the respective specific mutations in the protease gene. These may confer drug resistance to specific HIV protease inhibitors and have been identified in clinical specimens from individuals with therapeutic failure. | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | recombinant | Platinum | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available | |
006N-02608 | Nucleic Acid |
pHIV-1_pr63P-71V-82T-84V
Antiviral resistant strain |
Protease mutant with discrete mutations relevant for drug resistance to protease inhibitors | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Clade B | Platinum | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available | |
006N-03078 | Nucleic Acid |
pHIV-1_rt-D67N
Antiviral resistant strain |
Plasmid contains the entire genome of HIV-1 with specific mutations in the reverse transcriptase gene, which can confer drug resistance to specific HIV-1 inhibitors. The respective mutations have been reported in viruses from HIV-infected individuals on reverse transcriptase inhibitors with virologic therapy failure. | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Subtype B | recombinant | Platinum | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available |
006N-03079 | Nucleic Acid |
pHIV-1_rt-K103N
Antiviral resistant strain |
Plasmid contains the entire genome of HIV-1 with specific mutations in the reverse transcriptase gene, which can confer drug resistance to specific HIV-1 inhibitors. The respective mutations have been reported in viruses from HIV-infected individuals on reverse transcriptase inhibitors with virologic therapy failure. | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Subtype B | recombinant | Platinum | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available |
006N-03080 | Nucleic Acid |
pHIV-1_rt-M184V
Antiviral resistant strain |
Plasmid contains the entire genome of HIV-1 with specific mutations in the reverse transcriptase gene, which can confer drug resistance to specific HIV-1 inhibitors. The respective mutations have been reported in viruses from HIV-infected individuals on reverse transcriptase inhibitors with virologic therapy failure. | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Subtype B | recombinant | Platinum | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available |
006N-03084 | Nucleic Acid |
pHIV-1_pr-L33F
Antiviral resistant strain |
Plasmid contains the entire genome of HIV-1 with specific mutations in the protease gene, which can confer drug resistance to specific HIV-1 PR inhibitors. The respective mutations have been reported in viruses from HIV-infected individuals on PR inhibitors with virologic therapy failure. | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Subtype B | recombinant | Platinum | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available |
006N-03072 | Nucleic Acid |
pHIV-1_pr-V82A
Antiviral resistant strain |
Plasmid contains the entire genome of HIV-1 with specific mutations in the viral protease gene, which can confer drug resistance to specific HIV-1 protease inhibitors. The respective mutations have been reported in viruses from HIV-infected individuals on protease inhibitors with virologic therapy failure. | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Subtype B | recombinant | Platinum | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available |
006N-03073 | Nucleic Acid |
pHIV-1_pr-L63P
Antiviral resistant strain |
Plasmid contains the entire genome of HIV-1 with a specific mutation in the protease gene, which has been described as a polymorphic mutation. It is unclear, whether it can confer drug resistance to specific HIV-1 PR inhibitors directly. It has been shown in cell culture that the presence of the 63P change leads to higher "replicative fitness" of the virus. The respective mutations have been reported in viruses from HIV-infected individuals on PR inhibitors with virologic therapy failure. | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Subtype B | recombinant | Platinum | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available |
006N-03074 | Nucleic Acid |
pHIV-1_pr-L90M
Antiviral resistant strain |
Plasmid contains the entire genome of HIV-1 with specific mutations in the protease gene, which can confer drug resistance to specific HIV-1 PR inhibitors. The respective mutations have been reported in viruses from HIV-infected individuals on PR inhibitors with virologic therapy failure. | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Subtype B | recombinant | Platinum | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available |
006N-03082 | Nucleic Acid |
pHIV-1_pr-M46I
Antiviral resistant strain |
Plasmid contains the entire genome of HIV-1 with specific mutations in the protease gene, which can confer drug resistance to specific HIV-1 PR inhibitors. The respective mutations have been reported in viruses from HIV-infected individuals on PR inhibitors with virologic therapy failure. | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Subtype B | recombinant | Platinum | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available |
006N-02575 | Nucleic Acid |
pHIV-1_pr84V
Antiviral resistant strain |
HIV-1, drug resistant point mutant of protease, selected by specific HIV protease inhibitors. | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Clade B | Platinum | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available | |
006N-02574 | Nucleic Acid |
pHIV-1_pr84A
Antiviral resistant strain |
HIV-1, drug resistant point mutant of protease, selected by specific HIV protease inhibitors in vivo | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Clade B | Platinum | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available | |
006N-02572 | Nucleic Acid |
pHIV-1_pr50L
Antiviral resistant strain |
HIV-1, drug resistant point mutant of protease, reported to be specifically selected by the HIV protease inhibitor atazanavir in vivo | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Clade B | Platinum | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available | |
006N-01922 | Nucleic Acid |
pHIV-1_pr10F-46I-71V-82A-84V
Antiviral resistant strain |
Recombinant HIV-1 plasmid (derived from pNL4-3) with the indicated mutations in the protease gene, which have been reported in the context of clinical drug resistance to HIV protease inhibitors. | Human immunodeficiency virus 1 | Human immunodeficiency virus type 1 | clade B | The recombinant clone NL4-3 was derived from proviral DNA isolated from human HIV-1 positive cells | Platinum | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available |
006N-01921 | Nucleic Acid |
pHIV-1_pr48V-90M
Antiviral resistant strain |
Recombinant HIV-1 virus with the indicated mutations in the protease gene. Mutations have been reported from drug resistant viral variants emerging in vivo, e.g. after treatment with the HIV protease inhibitor saquinavir | Human immunodeficiency virus 1 | Human immunodeficiency virus type 1 | clade B | The recombinant clone NL4-3 was derived from proviral DNA isolated from human HIV positive cells | Platinum | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available |
006N-02602 | Nucleic Acid |
pHIV-1_pr46I-47L-50V-82A-84V
Antiviral resistant strain |
Protease mutant with the indicated discrete mutations relevant for drug resistance to protease inhibitors | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Clade B | Platinum | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available | |
006N-03075 | Nucleic Acid |
pHIV-1_pr-L10F
Antiviral resistant strain |
Plasmid contains the entire genome of HIV-1 with specific mutations in the protease gene, which can confer drug resistance to specific HIV-1 PR inhibitors. The respective mutations have been reported in viruses from HIV-infected individuals on PR inhibitors with virologic therapy failure. | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Subtype B | recombinant | Platinum | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available |
006N-03076 | Nucleic Acid |
pHIV-1_pr-L24I
Antiviral resistant strain |
Plasmid contains the entire genome of HIV-1 with specific mutations in the protease gene, which can confer drug resistance to specific HIV-1 PR inhibitors. The respective mutations have been reported in viruses from HIV-infected individuals on PR inhibitors with virologic therapy failure. | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Subtype B | recombinant | Platinum | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available |
006N-03081 | Nucleic Acid |
pHIV-1_pr-L10I
Antiviral resistant strain |
Plasmid contains the entire genome of HIV-1 with specific mutations in the protease gene, which can confer drug resistance to specific HIV-1 PR inhibitors. The respective mutations have been reported in viruses from HIV-infected individuals on PR inhibitors with virologic therapy failure. | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Subtype B | recombinant | Platinum | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available |
006N-03083 | Nucleic Acid |
pHIV-1_pr-K20R
Antiviral resistant strain |
Plasmid contains the entire genome of HIV-1 with specific mutations in the protease gene, which can confer drug resistance to specific HIV-1 PR inhibitors. The respective mutations have been reported in viruses from HIV-infected individuals on PR inhibitors with virologic therapy failure. | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Subtype B | recombinant | Platinum | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available |
006N-03077 | Nucleic Acid |
pHIV-1_pr-M36V
Antiviral resistant strain |
Plasmid contains the entire genome of HIV-1 with specific mutations in the protease gene, which can confer drug resistance to specific HIV-1 PR inhibitors. The respective mutations have been reported in viruses from HIV-infected individuals on PR inhibitors with virologic therapy failure. | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Subtype B | recombinant | Platinum | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available |
022N-03916 | Nucleic Acid |
T7-driven tetracistronic Ebola virus trVLP system expressing a Marburg virus glycoprotein and with a Nano-luciferase reporter (pT7.1-4cis-EBOV-vRNA-MARV-GP-nluc), recombinant non-infectious system Ebola virus Mayinga / Marburg virus Musoke (8 plasmids)
Antiviral resistant strain, Reference Strain |
Reverse genetics-based life cycle modelling system that allows modelling of Ebola virus genome replication and transcription, viral protein synthesis, virus assembly, budding, and Marburg virus entry into target cells under BSL1 conditions. Consists of 1) a plasmid encoding a T7-driven tetracistronic minigenome encoding a Nano luciferase reporter and the Ebola virus proteins VP40 and VP24, and the Marburg virus protein GP; 2) expression plasmids for the Ebola virus protein NP, VP35, VP30, and L; and 3) expression plasmids for the accessory proteins T7 polymerase (for initial transcription of the minigenome), Tim1 (attachment factor) and firefly luciferase (as control). Access is restricted to non-commercial research institutions only. Further descriptions of the different trVLP systems can be found at https://www.fli.de/en/institutes/institute-of-molecular-virology-and-cell-biology-imvz/laboratories/laboratory-for-molecular-biology-of-filoviruses/ | Marburg marburgvirus | Marburgvirus | Silver | In stock | RG1 | FLI | 900€ | View all details on this product . . . | Free access available |